`

Arovella Therapeutics ASX: ALA

Biotechnology Research

Specialities :
Cell therapy
Oncology
Inkt cell therapy
Invariant natural killer t (inkt) cell therapy platform
Blood cancers

+11

revenue-icon Revenue
< 1M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About Arovella Therapeutics ASX: ALA

What does Arovella therapeutics asx: ala do?+

Biotechnology, cell therapy, oncology, iNKT cell therapy, invariant natural killer T (iNKT) cell therapy platform, blood cancers, solid tumours, gastric & pancreatic cancers

What are Arovella therapeutics asx: ala's specialties? +

Cell therapy,oncology,inkt cell therapy,invariant natural killer t (inkt) cell therapy platform,blood cancers,oromist technology,reformulate existing pharmaceuticals,oral spray,insomnia,zolpimist,anagrelide,metastatic disease,migraine headaches,motion sickness,drug-resistant epilepsy,and biotechnology

What is Arovella therapeutics asx: ala's industry? +

Arovella therapeutics asx: ala operates in the Biotechnology research industry.

What is Arovella therapeutics asx: ala's revenue? +

Arovella therapeutics asx: ala's revenue is < 1m

What is Arovella therapeutics asx: ala's company size? +

Arovella therapeutics asx: ala has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.